Clinical effect of Lingnan Chen's flying needle in treating postmenopausal osteoporosis

Phase 1

• Conditions: Postmenopausal osteoporosis

• Registration Number: ITMCTR2000003117
• Lead Sponsor: The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Aged 45 to 70 years, menopause time more than 1 year;
2. All patients with bone density T value <= -2.5 measured by dual energy X-ray absorptiometry (DXA);
3. Patients who agree to enter the survey and can communicate better in language or writing.

Exclusion Criteria

1. Patients with essential cerebrovascular diseases, liver and kidney dysfunction, and severe hematopoietic system diseases etc.;
2. Patients with malignant tumor, tuberculosis and other diseases;
3. Patients with osteoporosis due to exclusion of other factors, such as hyperparathyroidism, Paralysis, etc.;
4. With serious ruggedness, disability, etc.;
5. Patients with a history of peptic ulcer, indigestion;
6. Have received hormone replacement therapy (HRT) in the past 1 year or have taken influence on bone metabolism within 6 months before enrollment Drugs, such as bisphosphate, cortisol, calcium tablets, vitamin D, fluoride, estrogen, etc.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone mineral density;Insulin-like growth factor;Growth factor;

Secondary Outcome Measures

Name	Time	Method
Quality of life score;PINP;Sex hormone;